Printer-friendly versionFunding from Finland, Netherlands, Norway, Sweden and UK will allow Ipas to promote the new abortion pill known as Medabon in Nepal   European Donor Countries Fund Pro-Abortion Efforts Globally Ipas, the international organization that trains health personnel in abortion using the hand held abortion device and abortion pills, has announced the receipt of new funds from the governments of Finland, the Netherlands, Norway, Sweden, and the United Kingdom. The new funds will allow Ipas to increase its efforts to advocate for legal abortion, to influence health ministers, and to distribute hundreds of thousands of reusable plastic manual vacuum aspirators through their affiliates in over 13 countries in Latin America, Africa, and Asia. This funding will allow Ipas to promote the new abortion pill known as Medabon in Nepal, the first country to register the medication. Medabon is a registered trademark of Concept Foundation and is a specifically packaged combination of mifepristone and misoprostol for abortion in the first nine weeks of pregnancy. The drugs cause uterine contractions and induction of labor resulting in the abortion of the unborn child. Efforts to register the drug are underway in nine selected countries including: Ethiopia, Ghana, India, South Africa, and Vietnam. Ipas is assisting the efforts of the government of Nepal to integrate the abortion pills with primary health care on the community level throughout the country. Abortions through the use of medications for so-called “medical abortion” are increasingly promoted for use in settings with minimal resources in lieu of surgical abortion. The combination of medications results in a chemical abortion that is far from sound medical practice. Thirteen internationally known cases of women dying from chemical abortion using medications similar to Medabon have so far been reported from the United States, the United Kingdom, Sweden, France and Canada. Complications from the drug are rarely reported.